Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 44

1.

The telomere/telomerase binding factor PinX1 regulates paclitaxel sensitivity depending on spindle assembly checkpoint in human cervical squamous cell carcinomas.

Tian XP, Qian D, He LR, Huang H, Mai SJ, Li CP, Huang XX, Cai MY, Liao YJ, Kung HF, Zeng YX, Xie D.

Cancer Lett. 2014 Jul 18. pii: S0304-3835(14)00349-8. doi: 10.1016/j.canlet.2014.07.012. [Epub ahead of print]

PMID:
25045845
[PubMed - as supplied by publisher]
2.

PinX1 suppresses bladder urothelial carcinoma cell proliferation via the inhibition of telomerase activity and p16/cyclin D1 pathway.

Liu JY, Qian D, He LR, Li YH, Liao YJ, Mai SJ, Tian XP, Liu YH, Zhang JX, Kung HF, Zeng YX, Zhou FJ, Xie D.

Mol Cancer. 2013 Nov 23;12(1):148. doi: 10.1186/1476-4598-12-148.

PMID:
24268029
[PubMed - indexed for MEDLINE]
Free Article
3.

Overexpression of cystatin SN positively affects survival of patients with surgically resected esophageal squamous cell carcinoma.

Chen YF, Ma G, Cao X, Luo RZ, He LR, He JH, Huang ZL, Zeng MS, Wen ZS.

BMC Surg. 2013 May 28;13:15. doi: 10.1186/1471-2482-13-15.

PMID:
23711283
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

β-Catenin/POU5F1/SOX2 transcription factor complex mediates IGF-I receptor signaling and predicts poor prognosis in lung adenocarcinoma.

Xu C, Xie D, Yu SC, Yang XJ, He LR, Yang J, Ping YF, Wang B, Yang L, Xu SL, Cui W, Wang QL, Fu WJ, Liu Q, Qian C, Cui YH, Rich JN, Kung HF, Zhang X, Bian XW.

Cancer Res. 2013 May 15;73(10):3181-9. doi: 10.1158/0008-5472.CAN-12-4403. Epub 2013 Mar 28.

PMID:
23539445
[PubMed - indexed for MEDLINE]
Free Article
5.

The telomere/telomerase binding factor PinX1 is a new target to improve the radiotherapy effect of oesophageal squamous cell carcinomas.

Qian D, Zhang B, He LR, Cai MY, Mai SJ, Liao YJ, Liu YH, Lin MC, Bian XW, Zeng YX, Huang JJ, Kung HF, Xie D.

J Pathol. 2013 Apr;229(5):765-74. doi: 10.1002/path.4163. Epub 2013 Feb 22.

PMID:
23341363
[PubMed - indexed for MEDLINE]
6.

[Ear reconstruction after rupture of postauricular expanded flap].

Hu SD, He LR, Zhao YY, Jiang HY, Yang QH, Zhuang HX.

Zhonghua Zheng Xing Wai Ke Za Zhi. 2012 Sep;28(5):328-31. Chinese.

PMID:
23259303
[PubMed - indexed for MEDLINE]
7.

Using the theory of coevolution to predict protein-protein interactions in non-small cell lung cancer.

Zhang M, Chan MH, Tu WJ, He LR, Lee CM, He M.

Chin J Cancer. 2013 Feb;32(2):91-8. doi: 10.5732/cjc.012.10100. Epub 2012 Dec 14.

PMID:
23237220
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Nimotuzumab promotes radiosensitivity of EGFR-overexpression esophageal squamous cell carcinoma cells by upregulating IGFBP-3.

Zhao L, He LR, Xi M, Cai MY, Shen JX, Li QQ, Liao YJ, Qian D, Feng ZZ, Zeng YX, Xie D, Liu MZ.

J Transl Med. 2012 Dec 11;10:249. doi: 10.1186/1479-5876-10-249.

PMID:
23232108
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Dynamic protein-protein interaction subnetworks of lung cancer in cases with smoking history.

Yu W, He LR, Zhao YC, Chan MH, Zhang M, He M.

Chin J Cancer. 2013 Feb;32(2):84-90. doi: 10.5732/cjc.012.10099. Epub 2012 Nov 13.

PMID:
23149315
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Prognostic value of plasma human β-defensin 2 level on short-term clinical outcomes in patients with community-acquired pneumonia: a preliminary study.

Liu S, He LR, Wang W, Wang GH, He ZY.

Respir Care. 2013 Apr;58(4):655-61. doi: 10.4187/respcare.01827.

PMID:
23051183
[PubMed - indexed for MEDLINE]
Free Article
11.

Tyrosine-protein phosphatase nonreceptor type 12 is a novel prognostic biomarker for esophageal squamous cell carcinoma.

Cao X, Li Y, Luo RZ, He LR, Yang J, Zeng MS, Wen ZS.

Ann Thorac Surg. 2012 May;93(5):1674-80. doi: 10.1016/j.athoracsur.2011.12.056. Epub 2012 Mar 17.

PMID:
22429674
[PubMed - indexed for MEDLINE]
12.

The overexpression of IGFBP-3 is involved in the chemosensitivity of esophageal squamous cell carcinoma cells to nimotuzumab combined with cisplatin.

Zhao L, Li QQ, Zhang R, Xi M, Liao YJ, Qian D, He LR, Zeng YX, Xie D, Liu MZ.

Tumour Biol. 2012 Aug;33(4):1115-23. doi: 10.1007/s13277-012-0352-0. Epub 2012 Mar 3.

PMID:
22389159
[PubMed - indexed for MEDLINE]
13.

Low expression of IGFBP-3 predicts poor prognosis in patients with esophageal squamous cell carcinoma.

Zhao L, He LR, Zhang R, Cai MY, Liao YJ, Qian D, Xi M, Zeng YX, Xie D, Liu MZ.

Med Oncol. 2012 Dec;29(4):2669-76. doi: 10.1007/s12032-011-0133-4. Epub 2011 Dec 14.

PMID:
22167391
[PubMed - indexed for MEDLINE]
14.

[Clinical advances in non-invasive ventilation and cardiogenic acute pulmonary edema].

He LR, Kuang JL.

Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2011 Sep;23(9):574-6. Review. Chinese. No abstract available.

PMID:
21944183
[PubMed - indexed for MEDLINE]
Free Article
15.

Prognosticators and risk grouping in patients with lung metastasis from nasopharyngeal carcinoma: a more accurate and appropriate assessment of prognosis.

Cao X, Luo RZ, He LR, Li Y, Lin WQ, Chen YF, Wen ZS.

Radiat Oncol. 2011 Aug 26;6:104. doi: 10.1186/1748-717X-6-104.

PMID:
21871101
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Factors determining the survival of nasopharyngeal carcinoma with lung metastasis alone: does combined modality treatment benefit?

Cao X, He LR, Xie FY, Chen YF, Wen ZS.

BMC Cancer. 2011 Aug 24;11:370. doi: 10.1186/1471-2407-11-370.

PMID:
21864397
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

[Clinical significance of counting follicles in diagnosis of polycystic ovary syndrome by the three-dimensional ultrasound imaging with sonography based automated volume calculation method].

He LR, Zhou LX, Pan RK, Zhang X.

Zhonghua Fu Chan Ke Za Zhi. 2011 May;46(5):350-4. Chinese.

PMID:
21733371
[PubMed - indexed for MEDLINE]
18.

[Changes of soluble CD40 ligand in patients with hyperlipidemia of blood stasis syndrome and its clinical significance].

Jin L, He LR, Fu DY.

Zhongguo Zhong Xi Yi Jie He Za Zhi. 2011 Mar;31(3):315-8. Chinese.

PMID:
21485068
[PubMed - indexed for MEDLINE]
19.

Prognostic value of Wnt inhibitory factor-1 expression in hepatocellular carcinoma that is independent of gene methylation.

Huang L, Li MX, Wang L, Li BK, Chen GH, He LR, Xu L, Yuan YF.

Tumour Biol. 2011 Feb;32(1):233-40. doi: 10.1007/s13277-010-0117-6. Epub 2010 Oct 30.

PMID:
21052890
[PubMed - indexed for MEDLINE]
20.

Overexpression of eIF5A-2 is an adverse prognostic marker of survival in stage I non-small cell lung cancer patients.

He LR, Zhao HY, Li BK, Liu YH, Liu MZ, Guan XY, Bian XW, Zeng YX, Xie D.

Int J Cancer. 2011 Jul 1;129(1):143-50. doi: 10.1002/ijc.25669.

PMID:
20830705
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk